Abiomed Inc. (ABMD): Price and Financial Metrics
ABMD Price/Volume Stats
| Current price | $381.02 | 52-week high | $381.99 |
| Prev. close | $380.79 | 52-week low | $219.85 |
| Day low | $380.51 | Volume | 20,612,200 |
| Day high | $381.28 | Avg. volume | 611,028 |
| 50-day MA | $343.62 | Dividend yield | N/A |
| 200-day MA | $291.25 | Market Cap | 17.18B |
ABMD Stock Price Chart Interactive Chart >
Abiomed Inc. (ABMD) Company Bio
Abiomed is a publicly-traded medical device technology company that develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo. Michael R. Minogue is Chairman, CEO & President of the company, with Dr. Thorsten Siess as Chief Technology Officer and Dr. Chuck Simonton as Chief Medical Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients". As of 2022, the company had secured five FDA approvals and 1,408 patents with 1,416 pending. For fiscal year 2022, Abiomed reported $1.032 billion in revenue and reported diluted earnings per share was $2.98 for the year. (Source:Wikipedia)
ABMD Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABMD Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 42.05% |
| 5-year | 52.52% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | 10.79% |
| 2020 | 90.05% |